Obscene Jeans Corp. (OTCBB: OBJE) reached up 35.62% in morning trading to $.099 with 200K shares traded. Obscene Interactive, a division of Obscene Jeans Corp., is an emerging company ready to introduce innovative technology platforms that enhance the gaming experience across various digital platforms. Obscene Interactive, subsidiary of Obscene Jeans Corp. (OTCBB: OBJE.OB - News), announced that it has signed a deal to develop exciting new proprietary games in-house.
Keryx Biopharmaceuticals, Inc. (NasdaqCM:KERX) reached up 13.31% in morning trading to $1.64 with 3M shares traded. Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease. Keryx is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Keryx Biopharmaceuticals, Inc. (KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the 11th Annual JMP Securities Research Conference, which will be held at the Ritz Carlton Hotel in San Francisco. Mr. Bentsur's presentation is scheduled to take place on Tuesday, May 15, 2012 at 12:00 noon Pacific Time (3:00 p.m. Eastern).
Cytori Therapeutics (NasdaqGM:CYTX) reached up 11.95% in morning trading to $2.53 with 250K shares traded. Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Cytori Therapeutics (CYTX) announced yesterday afternoon that during the first quarter of 2012 they advanced its cardiac cell therapy product pipeline, grew the commercial business, and strengthened operational and financial performance, which encompasses management of expenses, strategic partnerships, and regulatory approvals. Of the seven active partnership discussions, the Company is focused on the two most advanced transactions with the goal of completing the first partnership in the near term.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
